Dr. Jörg Taubel, CEO of Richmond Pharmacology, will be attending the EASL 2024 Annual Meeting and International Liver Congress. This event, taking place from 5th to 8th June2024 at the MiCo Milano Convention Centre in Milan, Italy, is a key gathering for hepatology experts.
If you would like to connect with Dr. Taubel during the event, please reach out to arrange a meeting.
Richmond supports Beam Therapeutics to make significant step forward in potential one-time gene editing treatment for Alpha-1
March 30, 2026
Beam Therapeutics has announced compelling updated clinical data from its ongoing Phase 1/2 Trial of BEAM-302 as a potential treatment for Alpha-1 Antitrypsin Deficiency (AATD).
By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.